MARKET

MRTX

MRTX

Mirati Therapeut
NASDAQ
38.46
+0.06
+0.16%
After Hours: 40.00 +1.54 +4.00% 19:57 05/26 EDT
OPEN
38.04
PREV CLOSE
38.40
HIGH
41.63
LOW
37.53
VOLUME
1.77M
TURNOVER
0
52 WEEK HIGH
101.30
52 WEEK LOW
32.96
MARKET CAP
2.24B
P/E (TTM)
-2.9689
1D
5D
1M
3M
1Y
5Y
Noteworthy Thursday Option Activity: AI, AMBA, MRTX
NASDAQ · 4d ago
Mirati tumbles after study failure for cancer drug; Oppenheimer upgrades
Seeking Alpha · 4d ago
Mirati's (MRTX) Sitravatinib Fails Lung Cancer Study, Stock Down 8%
NASDAQ · 5d ago
Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 5d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mirati Therapeutics (MRTX), Wave Life Sciences (WVE) and UnitedHealth (UNH)
TipRanks · 5d ago
Barclays Maintains Mirati Therapeutics (MRTX) Overweight Recommendation
NASDAQ · 5d ago
BMO Capital Maintains Mirati Therapeutics (MRTX) Market Perform Recommendation
NASDAQ · 5d ago
Absci, Predictive Oncology top healthcare gainers; Annexon, Biocept among losers
Seeking Alpha · 5d ago
More
About MRTX
Mirati Therapeutics, Inc. is a commercial-stage oncology company. The Company is developing novel therapeutics to address the genetic and immunological promoters of cancer. The Company's product KRAZATI is an oral targeted treatment option for adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC). Its MRTX1133 is an investigational, selective, and potent KRAS G12D inhibitor. Its MRTX1719 is an investigational synthetic lethal PRMT5 inhibitor designed to specifically target the PRMT5/ methylthioadensoine (MTA) complex. Its MRTX0902 is a potent, selective SOS1 inhibitor, designed to improve anti-tumor efficacy in combination with targeted mitogen-activated protein kinase (MAPK)-pathway inhibitors. Its Sitravatinib is an investigational spectrum-selective kinase inhibitor designed to potently inhibit receptor tyrosine kinases (RTKs) and enhance immune responses through the inhibition of immunosuppressive signaling.

Webull offers kinds of Mirati Therapeutics Inc stock information, including NASDAQ:MRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRTX stock methods without spending real money on the virtual paper trading platform.